NCT05884892Recruiting
Egyptian Hypertrophic Cardiomyopathy Program
Source: ClinicalTrials.gov · Last updated 1 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 14 Dec 2022
- Start date
- 1 Jan 2014
- Primary completion date
- 1 Jan 2030
- Lead sponsor
- Magdi Yacoub Heart Foundation
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT05884892
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Jan 2014 to the primary completion date, 1 Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refusal to consent to participate in the registry program.
Who the study is looking for
- All patients diagnosed with hypertrophic cardiomyopathy (index patients) who are willing and consented to participate in the registry.
- All family members of index patients who are willing and consented to participate in the registry.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aswan Heart Centre - Magdi Yacoub Heart Foundation Coordinator of this site? Confirm its status | Aswān | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.